About this trial
The aim of this study is to demonstrate that cerebral blood flow and brain function do not resume after death declaration in organ donors who undergo normothermic regional perfusion to restore organ function following death determination by circulatory criteria, when appropriate safeguards are applied.
To assess the absence of cerebral perfusion and function, investigators will use continuous and comprehensive multimodal neuromonitoring throughout the withdrawal of life-sustaining therapies, the dying process and the NRP procedure.
Eligibility criteria
Qualifiers
Age > 18;
Planned DCD within the next 96 hours.
Disqualifiers
Coagulopathy (International normalized ratio > 1.5, prothrombin time > 45 seconds, platelets < 50);
Therapeutic anticoagulant medication administration.
Trial design
Treatments tested in this trial
- Neuromonitoring
Treatment groups
Locations
1Sponsors and collaborators
University of British Columbia
Lead sponsor